The following pages link to Nirsevimab
External toolsShowing 50 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Monoclonal antibody (links | edit)
- Antivenom (links | edit)
- Bronchiolitis (links | edit)
- Respiratory syncytial virus (links | edit)
- ATC code J (links | edit)
- ATC code J06 (links | edit)
- Antiserum (links | edit)
- Antimicrobial (links | edit)
- MedImmune (links | edit)
- Rho(D) immune globulin (links | edit)
- Humanized antibody (links | edit)
- Palivizumab (links | edit)
- List of therapeutic monoclonal antibodies (links | edit)
- Exbivirumab (links | edit)
- Libivirumab (links | edit)
- Sevirumab (links | edit)
- Tuvirumab (links | edit)
- Felvizumab (links | edit)
- Motavizumab (links | edit)
- Tefibazumab (links | edit)
- Urtoxazumab (links | edit)
- Pagibaximab (links | edit)
- Efungumab (links | edit)
- Raxibacumab (links | edit)
- Edobacomab (links | edit)
- Regavirumab (links | edit)
- Nebacumab (links | edit)
- Foravirumab (links | edit)
- Rafivirumab (links | edit)
- Panobacumab (links | edit)
- Hepatitis B immune globulin (links | edit)
- Suvizumab (links | edit)
- Actoxumab (links | edit)
- Bezlotoxumab (links | edit)
- ZMapp (links | edit)
- Rabies immunoglobulin (links | edit)
- Anthrax immune globulin (links | edit)
- Diridavumab (links | edit)
- Obiltoxaximab (links | edit)
- Immunoglobulin therapy (links | edit)
- Suvratoxumab (links | edit)
- Suptavumab (links | edit)
- Lenvervimab (links | edit)
- Ansuvimab (links | edit)
- COVID-19 drug development (links | edit)
- Casirivimab/imdevimab (links | edit)
- Atoltivimab/maftivimab/odesivimab (links | edit)
- Atoltivimab (links | edit)
- Maftivimab (links | edit)
- Odesivimab (links | edit)